NUTX

insider transactions

Nutex Health Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Cluster buy signal: 4 different insiders made open-market purchases in the last 365 days, totalling $45.7K.

Net shares · 365d

+491

491 buy · 0 sell

Net value · 365d

$45.7K

$45.7K in · $0 out

Sentiment · 365d

Net buying

100% buying · 0% selling

Open-market trades · 365d

491 buy · 0 sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Other·J
Jun 4, 26

Kelvin Spears

Director

$0

2.5K sh
Other·J
May 28, 26

Thomas T. Vo KEY

Chief Executive Officer

$0

75.7K sh
Grant·A
Apr 23, 26

Scott J Saunders

Director

$0

823 sh

Own +136%
Grant·A
Apr 23, 26

Michael Lee Reed

Director

$0

823 sh

Own +136%
Grant·A
Apr 23, 26

Frank E Jaumot

Director

$0

823 sh

Own +136%
Grant·A
Apr 23, 26

Cheryl Yvonne Grenas

Director

$0

823 sh

Own +136%
Other·J
Apr 9, 26

Thomas T. Vo KEY

Chief Executive Officer

$0

184.1K sh
Buy·P
Mar 20, 26

Frank E Jaumot

Director

$14.0K

150 sh · $93.56

Own New
Buy·P
Mar 19, 26

Warren Hosseinion KEY

President

$23.7K

252 sh · $94.07

Own +3%
Buy·P
Mar 17, 26

Kelvin Spears

Director

$945

10 sh · $94.46

Own +0%
Buy·P
Mar 13, 26

Pamela W. Montgomery

Chief Legal Officer-Healthcare

$7.0K

79 sh · $88.87

Own +3%
Exercise·M
Mar 11, 26

Jon Christian Bates KEY

Chief Financial Officer

$0

1.7K sh

Own +44%
Exercise·M
Mar 11, 26

Wesley Shane Bamburg

Chief Operating Officer

$0

2.4K sh

Own New
Exercise·M
Mar 10, 26

Thomas T. Vo KEY

Chief Executive Officer

$0

4.8K sh

Own +41%
Exercise·M
Mar 10, 26

Kelvin Spears

Director

$0

116 sh

Own +38%
Other·F
Mar 10, 26

Kelvin Spears

Director

$7.1K

82 sh · $86.22

Own -0%
Exercise·M
Mar 10, 26

Kelvin Spears

Director

$0

183 sh

Own +1%
Exercise·M
Mar 10, 26

Thomas T. Vo KEY

Chief Executive Officer

$0

4.8K sh

Own +33%
Other·F
Mar 10, 26

Thomas T. Vo KEY

Chief Executive Officer

$260.1K

3.0K sh · $86.22

Own -0%
Exercise·M
Mar 10, 26

Thomas T. Vo KEY

Chief Executive Officer

$0

8.3K sh

Own +0%
Exercise·M
Mar 10, 26

Pamela W. Montgomery

Chief Legal Officer-Healthcare

$0

1.5K sh

Own +41%
Other·F
Mar 10, 26

Pamela W. Montgomery

Chief Legal Officer-Healthcare

$66.9K

776 sh · $86.22

Own -22%
Exercise·M
Mar 10, 26

Pamela W. Montgomery

Chief Legal Officer-Healthcare

$0

2.1K sh

Own +152%
Exercise·M
Mar 10, 26

Elisa V Luqman

Chief Legal Officer - SEC

$0

1.5K sh

Own +52%
Other·F
Mar 10, 26

Elisa V Luqman

Chief Legal Officer - SEC

$67.6K

784 sh · $86.22

Own -25%
Exercise·M
Mar 10, 26

Elisa V Luqman

Chief Legal Officer - SEC

$0

2.1K sh

Own +195%
Exercise·M
Mar 10, 26

Warren Hosseinion KEY

President

$0

3.7K sh

Own +30%
Other·F
Mar 10, 26

Warren Hosseinion KEY

President

$282.3K

3.3K sh · $86.22

Own -30%
Exercise·M
Mar 10, 26

Warren Hosseinion KEY

President

$0

6.3K sh

Own +140%
Exercise·M
Mar 10, 26

Michael L. Chang

Chief Medical Officer

$0

1.9K sh

Own +53%
Other·F
Mar 10, 26

Michael L. Chang

Chief Medical Officer

$66.3K

769 sh · $86.22

Own -1%
Exercise·M
Mar 10, 26

Michael L. Chang

Chief Medical Officer

$0

2.1K sh

Own +3%
Exercise·M
Mar 10, 26

Jon Christian Bates KEY

Chief Financial Officer

$0

2.7K sh

Own +47%
Exercise·M
Mar 10, 26

Pamela W. Montgomery

Chief Legal Officer-Healthcare

$0

1.5K sh

Own +52%
Exercise·M
Mar 10, 26

Kelvin Spears

Director

$0

116 sh

Own +52%
Exercise·M
Mar 10, 26

Warren Hosseinion KEY

President

$0

3.7K sh

Own +42%
Grant·A
Jul 14, 25

Scott J Saunders

Director

$0

603 sh

Own New
Grant·A
Jul 14, 25

Michael Lee Reed

Director

$0

603 sh

Own New
Grant·A
Jul 14, 25

Frank E Jaumot

Director

$0

603 sh

Own New
Grant·A
Jul 14, 25

Cheryl Yvonne Grenas

Director

$0

603 sh

Own New

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 4, 2026	Kelvin Spears	Director	Other J	2.5K	—	—	$0
May 28, 2026	Thomas T. Vo KEY	Chief Executive Officer	Other J	75.7K	—	—	$0
Apr 23, 2026	Scott J Saunders	Director	Grant A	823	+136%	—	$0
Apr 23, 2026	Michael Lee Reed	Director	Grant A	823	+136%	—	$0
Apr 23, 2026	Frank E Jaumot	Director	Grant A	823	+136%	—	$0
Apr 23, 2026	Cheryl Yvonne Grenas	Director	Grant A	823	+136%	—	$0
Apr 9, 2026	Thomas T. Vo KEY	Chief Executive Officer	Other J	184.1K	—	—	$0
Mar 20, 2026	Frank E Jaumot	Director	Buy P	150	New	$93.56	$14.0K
Mar 19, 2026	Warren Hosseinion KEY	President	Buy P	252	+3%	$94.07	$23.7K
Mar 17, 2026	Kelvin Spears	Director	Buy P	10	+0%	$94.46	$945
Mar 13, 2026	Pamela W. Montgomery	Chief Legal Officer-Healthcare	Buy P	79	+3%	$88.87	$7.0K
Mar 11, 2026	Jon Christian Bates KEY	Chief Financial Officer	Exercise M	1.7K	+44%	—	$0
Mar 11, 2026	Wesley Shane Bamburg	Chief Operating Officer	Exercise M	2.4K	New	—	$0
Mar 10, 2026	Thomas T. Vo KEY	Chief Executive Officer	Exercise M	4.8K	+41%	—	$0
Mar 10, 2026	Kelvin Spears	Director	Exercise M	116	+38%	—	$0
Mar 10, 2026	Kelvin Spears	Director	Other F	82	-0%	$86.22	$7.1K
Mar 10, 2026	Kelvin Spears	Director	Exercise M	183	+1%	—	$0
Mar 10, 2026	Thomas T. Vo KEY	Chief Executive Officer	Exercise M	4.8K	+33%	—	$0
Mar 10, 2026	Thomas T. Vo KEY	Chief Executive Officer	Other F	3.0K	-0%	$86.22	$260.1K
Mar 10, 2026	Thomas T. Vo KEY	Chief Executive Officer	Exercise M	8.3K	+0%	—	$0
Mar 10, 2026	Pamela W. Montgomery	Chief Legal Officer-Healthcare	Exercise M	1.5K	+41%	—	$0
Mar 10, 2026	Pamela W. Montgomery	Chief Legal Officer-Healthcare	Other F	776	-22%	$86.22	$66.9K
Mar 10, 2026	Pamela W. Montgomery	Chief Legal Officer-Healthcare	Exercise M	2.1K	+152%	—	$0
Mar 10, 2026	Elisa V Luqman	Chief Legal Officer - SEC	Exercise M	1.5K	+52%	—	$0
Mar 10, 2026	Elisa V Luqman	Chief Legal Officer - SEC	Other F	784	-25%	$86.22	$67.6K
Mar 10, 2026	Elisa V Luqman	Chief Legal Officer - SEC	Exercise M	2.1K	+195%	—	$0
Mar 10, 2026	Warren Hosseinion KEY	President	Exercise M	3.7K	+30%	—	$0
Mar 10, 2026	Warren Hosseinion KEY	President	Other F	3.3K	-30%	$86.22	$282.3K
Mar 10, 2026	Warren Hosseinion KEY	President	Exercise M	6.3K	+140%	—	$0
Mar 10, 2026	Michael L. Chang	Chief Medical Officer	Exercise M	1.9K	+53%	—	$0
Mar 10, 2026	Michael L. Chang	Chief Medical Officer	Other F	769	-1%	$86.22	$66.3K
Mar 10, 2026	Michael L. Chang	Chief Medical Officer	Exercise M	2.1K	+3%	—	$0
Mar 10, 2026	Jon Christian Bates KEY	Chief Financial Officer	Exercise M	2.7K	+47%	—	$0
Mar 10, 2026	Pamela W. Montgomery	Chief Legal Officer-Healthcare	Exercise M	1.5K	+52%	—	$0
Mar 10, 2026	Kelvin Spears	Director	Exercise M	116	+52%	—	$0
Mar 10, 2026	Warren Hosseinion KEY	President	Exercise M	3.7K	+42%	—	$0
Jul 14, 2025	Scott J Saunders	Director	Grant A	603	New	—	$0
Jul 14, 2025	Michael Lee Reed	Director	Grant A	603	New	—	$0
Jul 14, 2025	Frank E Jaumot	Director	Grant A	603	New	—	$0
Jul 14, 2025	Cheryl Yvonne Grenas	Director	Grant A	603	New	—	$0

About NUTX insider trading

This page tracks insider transactions for Nutex Health Inc. (NUTX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.